There is strong evidence that human papillomaviruses (HPV) oncoproteins can promote tumor angiogenesis via the upregulation of HIF1/VEGF pathways, specifically manipulating aspects of the cellular hypoxic response [70,71]. The gene discussed is HIF1A; the disease is neoplasm.